Pluristem & Charite Expand Cooperation Agreement to Include Orthopedic Indications
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced it has expanded its five-year Collaborative Research Agreement with the Berlin-Brandenburg Center for Regenerative Therapy at Charité - University Medicine Berlin. The expanded agreement, which was executed on October 11th at the Berlin-Tel Aviv Business Forum in Tel Aviv, broadens the parties' cooperation to include identification of orthopedic indications that may be eligible for development under Europe's Adaptive Pathways and conditional marketing approval in the European Union....
View full press release